Myeloperoxidase, often shortened to MPO, is an enzyme released mainly by activated white blood cells during inflammation. In heart and artery health, an MPO blood test is used as a marker of vascular inflammation and oxidative stress, especially when clinicians want more information about plaque activity beyond a standard cholesterol panel. A high MPO result does not diagnose a heart attack by itself, and it does not replace troponin, ECG testing, blood pressure assessment, or imaging. It can, however, suggest that inflammatory activity around the artery wall may be higher than expected.
MPO results need context. Smoking, diabetes, kidney disease, gum disease, autoimmune inflammation, infection, strenuous exercise, and existing coronary artery disease can all influence the result. The test is most useful when it is interpreted with symptoms, traditional risk factors, LDL cholesterol or ApoB, hs-CRP, blood pressure, glucose markers, kidney function, and a clinician’s overall risk assessment.
- The MPO test measures free myeloperoxidase in blood, a white-blood-cell enzyme linked with vascular inflammation and oxidative stress.
- Many labs use cardiovascular risk cutoffs near <470 pmol/L, 470–539 pmol/L, and ≥540 pmol/L, but the lab report’s own reference range should guide interpretation.
- High MPO can suggest higher artery inflammation or plaque activity, but it does not prove that a plaque will rupture or that a heart attack is occurring.
- MPO is not the same as an MPO antibody or p-ANCA test, which is used in autoimmune vasculitis evaluation.
- Chest pain, shortness of breath, fainting, stroke symptoms, or sudden severe weakness need urgent care, regardless of the MPO result.
- A high MPO result should usually lead to a broader cardiovascular review, not a single-marker decision.
Table of Contents
- What the MPO Test Measures
- Why MPO Is Linked to Artery Inflammation
- MPO Results and Reference Ranges
- Causes of High MPO
- How MPO Compares With Other Heart Markers
- When the Test May Be Useful
- What to Do After a High MPO Result
- Limitations and Common Mistakes
What the MPO Test Measures
The MPO blood test measures myeloperoxidase, an enzyme stored inside certain white blood cells, especially neutrophils and monocytes. These cells release MPO when they become activated during inflammation. Once released, MPO helps generate reactive oxidants that can kill microbes. That immune function is useful during infection, but the same chemistry can also contribute to oxidative stress in blood vessels.
In cardiovascular testing, MPO is usually discussed as a marker of vascular inflammation. It reflects white blood cell activation, oxidative activity, and inflammatory stress that may affect the artery lining. This is different from measuring cholesterol particles directly. LDL cholesterol, non-HDL cholesterol, and ApoB describe the burden of atherogenic particles that can enter the artery wall. MPO gives a different signal: inflammatory activity that may make plaque biology more active.
The test is usually performed on a blood sample, commonly plasma, depending on the laboratory method. Some cardiovascular labs report MPO in pmol/L and place the result into low, moderate, or high risk categories. Because methods and cutoffs vary, the reference interval on the actual report should always be used.
MPO is not a routine screening test for everyone. Many people can estimate and reduce heart risk with standard tools: blood pressure, smoking status, diabetes status, family history, kidney function, cholesterol testing, and sometimes coronary artery calcium scoring. MPO may be considered when a clinician wants extra information about inflammatory or residual cardiovascular risk, especially in someone who already has risk factors.
It is also important to separate the cardiovascular MPO protein test from autoimmune MPO antibody testing. An MPO antibody test, often reported with p-ANCA or ANCA testing, looks for antibodies against myeloperoxidase and is used when doctors suspect certain forms of vasculitis. A cardiovascular MPO test measures the enzyme itself in the bloodstream. The names overlap, but the medical questions are different.
Why MPO Is Linked to Artery Inflammation
MPO is linked to artery disease because it sits at the crossroads of inflammation, oxidative stress, endothelial injury, and plaque activity. Atherosclerosis is not just cholesterol buildup. It is a long-term inflammatory process in which cholesterol-rich particles enter the artery wall, immune cells respond, and plaque can slowly grow or become unstable.
When white blood cells enter inflamed plaque, they can release MPO. MPO then helps produce oxidants such as hypochlorous acid. These oxidants can modify proteins, lipids, and the artery lining. In simple terms, MPO is one of the enzymes that can turn immune activation into chemical injury.
MPO may affect arteries in several ways:
- It can oxidize LDL particles, making them more likely to be taken up by immune cells inside plaque.
- It can reduce nitric oxide availability, which may impair normal blood vessel relaxation.
- It can promote endothelial dysfunction, meaning the inner lining of blood vessels behaves less normally.
- It can contribute to plaque inflammation and weakening of the fibrous cap.
- It can interact with clotting and platelet activity in ways that may matter during acute coronary events.
This does not mean MPO is the single cause of heart disease. Heart risk is usually multi-factorial. LDL particles, blood pressure, smoking, insulin resistance, diabetes, chronic kidney disease, obesity, sleep apnea, genetics, and inflammation can all contribute. MPO is best viewed as one part of this larger picture.
A useful way to think about MPO is this: cholesterol-related markers describe how much atherogenic material is available to build plaque, while MPO may reflect inflammatory activity around the plaque environment. For example, someone with high LDL cholesterol and high MPO may have both a high particle burden and active inflammation. Someone with low LDL cholesterol but high MPO may need a closer look for non-cholesterol drivers such as smoking, diabetes, kidney disease, autoimmune disease, infection, or periodontal disease.
MPO also overlaps with other inflammatory markers, but it is not identical to them. High-sensitivity C-reactive protein, or hs-CRP, reflects systemic inflammation made largely through liver signaling. MPO is more closely tied to activated white blood cells and oxidative enzyme activity. When clinicians use both, they are usually asking whether inflammation is broad, vascular, or both. For more context on pairing inflammation with cholesterol testing, see hs-CRP and lipid panel interpretation.
MPO Results and Reference Ranges
MPO results are commonly reported in pmol/L when used in cardiovascular risk testing. Some commercial cardiovascular labs use categories similar to low risk below 470 pmol/L, moderate risk from 470 to 539 pmol/L, and high risk at 540 pmol/L or higher. These are not universal diagnostic cutoffs. They are lab-specific risk categories, and they should not be treated like the troponin cutoff used for heart injury.
| MPO result | Common interpretation | How to use it |
|---|---|---|
| <470 pmol/L | Lower MPO category | Usually suggests lower measured vascular inflammatory activity, but it does not erase risk from LDL, blood pressure, diabetes, smoking, or family history. |
| 470–539 pmol/L | Moderate MPO category | May justify reviewing inflammation, lifestyle factors, gum disease, glucose control, kidney function, and lipid-related risk. |
| ≥540 pmol/L | High MPO category | Suggests higher inflammatory or oxidative activity and should be interpreted with cardiovascular risk factors, symptoms, and other tests. |
A high MPO result is not the same as a positive heart attack test. In emergency care, the main blood marker for heart muscle injury is troponin, especially high-sensitivity troponin. MPO may rise in settings linked with vascular inflammation or acute coronary risk, but it does not diagnose myocardial infarction on its own. A person with chest pain needs urgent evaluation with symptoms, ECG findings, serial troponin testing, and clinical judgment. For acute heart injury patterns, troponin I and troponin T interpretation is much more central.
Low or normal MPO
A low or normal MPO result generally means the test did not detect increased MPO-related vascular inflammatory activity at that time. That is reassuring in a narrow sense, but it is not a guarantee of low cardiovascular risk. A person can still have high LDL cholesterol, high ApoB, high Lp(a), hypertension, diabetes, or significant coronary calcium with a normal MPO.
Low MPO is usually not a medical problem in cardiovascular testing. Rare inherited MPO deficiency exists, but it is a separate issue and is not what most cardiovascular MPO testing is designed to evaluate.
Moderately elevated MPO
A moderate MPO result often means “look for context.” It may appear in people with early cardiometabolic risk, smoking exposure, obesity, insulin resistance, periodontal disease, chronic inflammatory conditions, or existing plaque burden. It may also occur temporarily after acute illness or intense exertion.
A reasonable next step is not to panic, but to repeat the broader cardiovascular risk review. That may include lipid markers, blood pressure, glucose and insulin-related markers, kidney function, medication adherence, sleep quality, exercise habits, and inflammatory conditions.
High MPO
A high MPO result suggests increased white blood cell activation or vascular inflammatory activity. It can strengthen the case for more aggressive risk factor control, especially when other markers also point in the same direction. For example, high MPO plus high ApoB, high hs-CRP, diabetes, smoking, or known coronary artery disease is more concerning than high MPO alone.
A high result should also trigger a search for non-cardiac reasons. Infection, autoimmune inflammation, chronic gum disease, kidney disease, cancer, and recent strenuous exercise may raise MPO or reflect inflammatory activity that is not specific to coronary plaque.
Causes of High MPO
High MPO usually means white blood cells are more activated than expected, but the reason can vary. The result should be interpreted as a signal, not a diagnosis.
Common causes and associations include:
- Atherosclerosis and coronary artery disease. MPO has been studied in people with coronary plaque, acute coronary syndrome, and future cardiovascular event risk.
- Smoking. Tobacco smoke increases oxidative stress and vascular inflammation.
- Diabetes and insulin resistance. High glucose and metabolic stress can promote inflammation and endothelial dysfunction. If glucose control is uncertain, HbA1c testing can help clarify longer-term blood sugar exposure.
- High LDL particle burden. LDL cholesterol and ApoB-rich particles provide the material that drives atherosclerotic plaque formation. MPO may add an inflammatory layer to that risk.
- Hypertension. High blood pressure injures the artery wall and can amplify vascular stress.
- Chronic kidney disease. Kidney disease is strongly tied to inflammation, oxidative stress, and high cardiovascular risk.
- Periodontal disease. Inflamed gums can create chronic immune activation and are often overlooked.
- Autoimmune or inflammatory disease. Conditions such as rheumatoid arthritis and lupus can raise vascular risk through systemic inflammation.
- Recent infection or acute illness. A respiratory infection, fever, or other inflammatory event may temporarily affect inflammatory markers.
- Strenuous exercise or tissue injury. Heavy exercise can activate inflammatory and oxidative pathways, especially if the test is drawn soon afterward.
The pattern matters more than a single number. A person with high MPO, high hs-CRP, high WBC count, and symptoms of infection should be evaluated differently from someone with high MPO, high ApoB, hypertension, and a strong family history of early heart disease. When white blood cell patterns are abnormal, a CBC with differential can help show whether neutrophils, lymphocytes, or other blood cell types are part of the picture.
Some causes are modifiable. Smoking cessation, better blood pressure control, improved glucose control, treatment of gum disease, sleep apnea management, regular physical activity, and appropriate lipid-lowering therapy can all reduce vascular stress. MPO is not usually treated directly in routine care; clinicians treat the risk drivers behind it.
How MPO Compares With Other Heart Markers
MPO is one cardiovascular biomarker, but it answers a narrower question than many people expect. It is not a replacement for standard risk assessment, and it is not the main test for chest pain.
| Marker | What it mainly reflects | Best use |
|---|---|---|
| MPO | White blood cell activation, vascular inflammation, oxidative stress | Additional risk context in selected people, especially when inflammation or residual risk is suspected |
| hs-CRP | Systemic inflammation | Broad inflammatory risk signal, often used with lipid markers |
| LDL cholesterol | Cholesterol carried in LDL particles | Core treatment target for atherosclerotic cardiovascular risk |
| ApoB | Number of atherogenic particles | Particle-related risk, especially when triglycerides, diabetes, obesity, or metabolic syndrome are present |
| Lp(a) | Inherited lipoprotein-related risk | Lifetime risk clarification, especially with family history or early heart disease |
| Troponin | Heart muscle injury | Emergency and clinical evaluation of suspected heart attack or myocardial injury |
| BNP or NT-proBNP | Heart wall stretch and heart failure stress | Evaluation and monitoring of suspected or known heart failure |
For long-term artery risk, ApoB and LDL cholesterol usually carry more direct treatment implications than MPO. High ApoB means there are too many atherogenic particles entering and interacting with the artery wall. MPO may help show whether inflammatory activity is also elevated, but lowering ApoB remains one of the most evidence-based ways to reduce atherosclerotic risk. For a clearer comparison, see ApoB and LDL cholesterol interpretation.
MPO also differs from Lp-PLA2, another vascular inflammation-related marker. Lp-PLA2 is associated with inflammation in atherosclerotic plaques and oxidized phospholipids, while MPO reflects neutrophil and monocyte enzyme activity. They can overlap clinically, but they are not interchangeable. If both are elevated, the result may suggest a broader inflammatory plaque-risk pattern, especially when lipid markers are also abnormal.
MPO is sometimes grouped with advanced cardiovascular biomarkers such as oxidized LDL, hs-CRP, Lp-PLA2, ApoB, Lp(a), and ceramides. That does not mean every person needs all of these tests. The more advanced the panel, the more important it becomes to ask whether the results will change a treatment decision.
When the Test May Be Useful
The MPO test may be useful when a clinician wants additional information about cardiovascular inflammation, especially in people who already have risk factors. It is most helpful when the result can guide a real next step.
Possible situations include:
- A person has known coronary artery disease and the clinician wants to assess residual inflammatory risk.
- Standard cholesterol levels look acceptable, but the person has diabetes, smoking exposure, kidney disease, or strong family history.
- hs-CRP is elevated and the clinician wants another inflammation-related marker with a more vascular focus.
- A person has multiple cardiometabolic risks and the care team is deciding how aggressively to address LDL, ApoB, blood pressure, weight, glucose, and lifestyle.
- A previous MPO result was high, and the clinician wants to see whether risk factor treatment and inflammation control are improving the pattern.
MPO testing is less useful when it is ordered without a plan. For example, testing a low-risk person with no symptoms, normal blood pressure, favorable lipids, no diabetes, no smoking, and no family history may create more confusion than benefit. A mildly high result in that setting could lead to anxiety and extra testing without clear evidence of improved outcomes.
The test also has limited value during obvious acute illness. If someone has pneumonia, a flare of autoimmune disease, or a recent intense endurance event, a high MPO may reflect that short-term inflammatory state. In those cases, the clinician may decide to repeat testing later rather than overinterpret one result.
MPO can be part of a broader cardiovascular biomarker panel, but it should not crowd out the basics. Blood pressure control, smoking cessation, LDL or ApoB lowering when appropriate, diabetes prevention or treatment, physical activity, sleep quality, weight management, and diet quality have much stronger evidence for improving outcomes than chasing small changes in a single inflammatory marker.
What to Do After a High MPO Result
A high MPO result deserves follow-up, but the follow-up should be structured. The result should be used to look for risk drivers and decide whether prevention needs to be stronger.
Start with symptoms. Chest pressure, pain spreading to the arm or jaw, shortness of breath, fainting, sudden sweating with weakness, stroke-like symptoms, or severe sudden fatigue should be treated as urgent, especially in someone with known heart disease or major risk factors. MPO is not the right tool for deciding whether emergency symptoms are safe.
Next, review the full cardiovascular picture. Useful companion information may include:
- LDL cholesterol, non-HDL cholesterol, triglycerides, HDL cholesterol, and ApoB
- Lp(a), especially if there is early heart disease in the family
- Blood pressure readings, including home readings when available
- Fasting glucose, HbA1c, and diabetes status
- Kidney function, including creatinine and eGFR
- hs-CRP and CBC with differential when inflammation is suspected
- Smoking status, sleep apnea symptoms, gum health, and exercise pattern
- Current medications and whether they are being taken consistently
A high MPO result may push the conversation toward more aggressive prevention. That could mean intensifying lipid-lowering therapy, treating high blood pressure more consistently, improving glucose control, stopping smoking, treating periodontal disease, addressing sleep apnea, or increasing physical activity in a safe way.
Diet changes should focus on patterns that lower cardiometabolic risk rather than one “anti-MPO” food. A Mediterranean-style pattern is a practical option for many people: vegetables, beans, lentils, fruit, nuts, olive oil, fish, whole grains, and fewer refined carbohydrates, processed meats, and fried foods. Weight loss can help when excess body fat, insulin resistance, fatty liver, or high blood pressure are part of the risk pattern.
Exercise usually helps long-term vascular health, but timing matters for testing. Very strenuous exercise shortly before blood work may affect inflammatory or muscle-related markers. If a result is unexpectedly high after a hard race, intense training block, illness, or injury, the clinician may recommend repeating the test after recovery.
Do not use supplements as the main response to high MPO. Some nutrients and dietary patterns may reduce oxidative stress, but supplement claims often outrun evidence. The most reliable actions are the unglamorous ones: stop smoking, control blood pressure, lower ApoB-containing particles when indicated, manage diabetes, treat inflammation sources, improve fitness, and sleep well.
Limitations and Common Mistakes
The MPO test has real biological relevance, but it has limits. Misreading those limits can lead to anxiety, overtesting, or false reassurance.
A common mistake is treating MPO as a heart attack test. Troponin is the blood marker used to detect heart muscle injury. MPO may provide risk information in some settings, but it cannot rule in or rule out a heart attack. A normal MPO should never be used to ignore chest pain.
Another mistake is interpreting MPO without the lab’s reference range. Different assays can use different sample types, methods, and cutoffs. A number that looks “high” on one report may not map perfectly to another laboratory’s method.
People also overinterpret single results. MPO can reflect a temporary inflammatory state. Infection, injury, autoimmune flare, dental inflammation, and intense exercise can all complicate interpretation. Repeating the test after the temporary trigger has resolved may be more useful than reacting immediately.
A high MPO result should not automatically lead to imaging, procedures, or medication changes. The result should be placed into a decision pathway. If a person already has high ApoB, smoking, diabetes, and hypertension, the treatment priorities are already clear. MPO may add urgency, but it may not change the plan much. If a person has unclear risk, the clinician may consider whether other tools, such as coronary artery calcium scoring or advanced lipid testing, would be more actionable.
A normal MPO result should not create false comfort. Many heart attacks occur in people whose risk was driven by LDL particles, blood pressure, diabetes, smoking, or inherited factors rather than a single elevated inflammatory marker. Normal MPO does not cancel the need to treat major risk factors.
MPO also should not be confused with MPO antibodies. If a report says “MPO antibody,” “anti-MPO,” or appears within an ANCA panel, that is usually a vasculitis-related test, not the cardiovascular MPO protein test. The units are often different, and the interpretation is completely different.
Finally, the MPO test should not be used as a stand-alone wellness score. It is most useful when it helps answer a specific medical question: Is inflammatory vascular risk higher than expected? Are there untreated drivers of artery inflammation? Should prevention be intensified? Has a previously high inflammatory pattern improved after risk factor treatment?
References
- Cardio IQ Myeloperoxidase (MPO) | Test Summary | Quest Diagnostics 2026 (Test Directory)
- Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population 2025 (Study)
- The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress 2024 (Review)
- Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction 2024 (Review)
- Association of chronic neutrophil activation with risk of mortality 2023 (Study)
- Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis 2019 (Systematic Review)
Disclaimer
MPO results should be interpreted by a qualified clinician together with symptoms, medical history, medications, and other cardiovascular tests. A high MPO result does not diagnose a heart attack, and a normal MPO result does not rule one out. Seek urgent medical care for chest pain, shortness of breath, fainting, stroke symptoms, or sudden severe weakness.
